Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens von der Grün

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Radiation Oncology (London, England)|May 27, 2020
Management of anal cancer patients - a pattern of care analysis in German-speaking countriesDaniel Martin, Jens von der Grün, Claus Rödel, et al.
Frontiers in Oncology|September 9, 2020
Sarcopenia Is Associated With Hematologic Toxicity During Chemoradiotherapy in Patients With Anal CarcinomaDaniel Martin, Jens von der Grün, Claus Rödel, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2024
A comprehensive and longitudinal evaluation of the different populations of lymphoid and myeloid cells in the peripheral blood of patients treated with chemoradiotherapy for head and neck cancerJens von der Grün, Martina Broglie, Matthias Guckenberger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 18, 2020
Acute organ toxicity correlates with better clinical outcome after chemoradiotherapy in patients with anal carcinomaDaniel Martin, Franz Rödel, Jens von der Grün, et al.
Head & Neck|December 7, 2018
Second infield re-irradiation with a resulting cumulative equivalent dose (EQD2<sub>max</sub> ) of >180 Gy for patients with recurrent head and neck cancerJens von der Grün, Janett Köhn, Britta Loutfi-Krauss, et al.
Cancers|April 17, 2019
Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go?Jens von der Grün, Franz Rödel, Christian Brandts, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 24, 2021
Patterns of care analysis for salivary gland cancer: a survey within the German Society of Radiation Oncology (DEGRO) and recommendations for daily practiceJens von der Grün, Claus Rödel, Sabine Semrau, et al.
BMC Urology|January 30, 2022
The routine use of LCD-Array hybridisation technique for HPV subtyping in the diagnosis of penile carcinoma compared to other methodsRia Winkelmann, Katrin Bankov, Jens von der Grün, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 7, 2021
Risk stratification by anamnesis increases SARS-CoV-2 test efficiency in cancer patientsChristian Cornelius Arnold, Jens von der Grün, Mark Christoph Brekner, et al.
Virchows Archiv : an International Journal of Pathology|January 13, 2022
Tumor-associated immune cell infiltrate density in penile squamous cell carcinomasLuca Hladek, Katrin Bankov, Jens von der Grün, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Radiation Oncology (London, England)|May 27, 2020
Management of anal cancer patients - a pattern of care analysis in German-speaking countriesDaniel Martin, Jens von der Grün, Claus Rödel, et al.
Frontiers in Oncology|September 9, 2020
Sarcopenia Is Associated With Hematologic Toxicity During Chemoradiotherapy in Patients With Anal CarcinomaDaniel Martin, Jens von der Grün, Claus Rödel, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2024
A comprehensive and longitudinal evaluation of the different populations of lymphoid and myeloid cells in the peripheral blood of patients treated with chemoradiotherapy for head and neck cancerJens von der Grün, Martina Broglie, Matthias Guckenberger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 18, 2020
Acute organ toxicity correlates with better clinical outcome after chemoradiotherapy in patients with anal carcinomaDaniel Martin, Franz Rödel, Jens von der Grün, et al.
Head & Neck|December 7, 2018
Second infield re-irradiation with a resulting cumulative equivalent dose (EQD2<sub>max</sub> ) of >180 Gy for patients with recurrent head and neck cancerJens von der Grün, Janett Köhn, Britta Loutfi-Krauss, et al.
Cancers|April 17, 2019
Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go?Jens von der Grün, Franz Rödel, Christian Brandts, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 24, 2021
Patterns of care analysis for salivary gland cancer: a survey within the German Society of Radiation Oncology (DEGRO) and recommendations for daily practiceJens von der Grün, Claus Rödel, Sabine Semrau, et al.
BMC Urology|January 30, 2022
The routine use of LCD-Array hybridisation technique for HPV subtyping in the diagnosis of penile carcinoma compared to other methodsRia Winkelmann, Katrin Bankov, Jens von der Grün, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 7, 2021
Risk stratification by anamnesis increases SARS-CoV-2 test efficiency in cancer patientsChristian Cornelius Arnold, Jens von der Grün, Mark Christoph Brekner, et al.
Virchows Archiv : an International Journal of Pathology|January 13, 2022
Tumor-associated immune cell infiltrate density in penile squamous cell carcinomasLuca Hladek, Katrin Bankov, Jens von der Grün, et al.
Pageof 6